In a NALM6 acute lymphoblastic leukemia model, Hamieh et al. showed that the decrease in CD19 expression on the surface of NALM6 cells co-cultured with anti-CD19 CAR-T cells was partially reversed after six days. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.